# FDA Inspection 1265326 - Octapharma Plasma, Inc. - March 14, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/c757f2b2-79aa-4304-bf82-cf14cefe33aa
Source feed: FDA_Inspections

> FDA Inspection 1265326 for Octapharma Plasma, Inc. on March 14, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265326
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2025-03-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1265326 - 2025-03-14](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/e1cd8467-461b-4ea5-a5b0-bab3eea4050a)
- [FDA Inspection 1102521 - 2019-09-23](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/261382e7-e45c-4e25-88cf-eca7e0ebcfb3)

Company: https://www.globalkeysolutions.net/companies/octapharma-plasma-inc/e0dc45cc-d385-40df-bbf1-3cd5148cbbfc

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d